The Alliance Advancement Series
Presented on: Tuesday, August 11, 2020
Immunologic rejection continues to be a significant barrier to successful, long term graft survival in organ transplant recipients. Understanding how anti-HLA antibodies are involved in transplantation is key to appropriately tailoring a patient’s immunosuppression plan. This webinar will focus on understanding how antibodies are involved in transplant rejection, the role the histocompatibility laboratory plays in the transplant process, and what barriers remain in identifying and treating antibody mediated rejection in patients.
At the end of the webinar, participants should be able to:
- Describe what antibodies are and how they affect organ transplant survival.
- Recognize how the histocompatibility laboratory tests patients for anti-HLA antibodies.
- Discuss the challenges and limitations to antibody testing in the laboratory.
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.